Gridelli, C; Ciuleanu, T; Domine, M; Szczesna, A; Bover, I; Cobo, M; Kentepozidis, N; Zarogoulidis, K; Kalofonos, C; Kazarnowisz, A; Korozan, M; de las Penas, R; Majem, M; Chella, A; Griesinger, F; Bournakis, E; Sadjadian, P; Kotsakis, A; Chinet, T; Syrigos, KN; Correale, P; Gallou, C; Jamet, JM; Vetsika, EK; Kosmatopoulos, K; Georgoulias, V – 2020 – 10.1038/s41416-020-0785-y
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial
by prodriguez | Jan 1, 2020 | Publicaciones - B-22 | 0 comments